MedPath

JAMP GEFITINIB

JAMP GEFITINIB

Approved
DIN Number

02500663

Drug Class

Human

Market Date

Dec 23, 2020

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02500663
AIG Number0149783001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EB01 GEFITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

GEFITINIBActive
Strength: 250 MG
Monograph: GEFITINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.